250 related articles for article (PubMed ID: 30827328)
1. [Review on Treatment Modalities for Resectable IIIa/N2 Non-small Cell Lung Cancer].
Xu Z; Xing P; Ma D; Zhu Y; Ying J; Li J
Zhongguo Fei Ai Za Zhi; 2019 Feb; 22(2):111-117. PubMed ID: 30827328
[TBL] [Abstract][Full Text] [Related]
2. Resectable Clinical N2 Non-Small Cell Lung Cancer; What Is the Optimal Treatment Strategy? An Update by the British Thoracic Society Lung Cancer Specialist Advisory Group.
Evison M; Clive A; Castle L; Powell H; Thomas R; Buttery R; Masani V; Harden S; West D; Woolhouse I
J Thorac Oncol; 2017 Sep; 12(9):1434-1441. PubMed ID: 28624466
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK
Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759
[TBL] [Abstract][Full Text] [Related]
4. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant Therapy in Non-Small Cell Lung Cancer.
Zheng Y; Jaklitsch MT; Bueno R
Surg Oncol Clin N Am; 2016 Jul; 25(3):567-84. PubMed ID: 27261916
[TBL] [Abstract][Full Text] [Related]
6. Results of trimodality therapy in patients with stage IIIA (N2-bulky) and stage IIIB non-small-cell lung cancer.
Li J; Dai CH; Yu LC; Chen P; Li XQ; Shi SB; Wu JR
Clin Lung Cancer; 2009 Sep; 10(5):353-9. PubMed ID: 19808194
[TBL] [Abstract][Full Text] [Related]
7. The role of chemotherapy in early stage of non-small cell lung cancer.
Souquet PJ; Geriniere L
Lung Cancer; 2001 Dec; 34 Suppl 2():S155-8. PubMed ID: 11720758
[TBL] [Abstract][Full Text] [Related]
8. Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE).
Eberhardt WE; Pöttgen C; Gauler TC; Friedel G; Veit S; Heinrich V; Welter S; Budach W; Spengler W; Kimmich M; Fischer B; Schmidberger H; De Ruysscher D; Belka C; Cordes S; Hepp R; Lütke-Brintrup D; Lehmann N; Schuler M; Jöckel KH; Stamatis G; Stuschke M
J Clin Oncol; 2015 Dec; 33(35):4194-201. PubMed ID: 26527789
[TBL] [Abstract][Full Text] [Related]
9. Current status of induction treatment for N2-Stage III non-small cell lung cancer.
Yamaguchi M; Sugio K
Gen Thorac Cardiovasc Surg; 2014 Nov; 62(11):651-9. PubMed ID: 25355643
[TBL] [Abstract][Full Text] [Related]
10. Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer.
Choi NC; Carey RW; Daly W; Mathisen D; Wain J; Wright C; Lynch T; Grossbard M; Grillo H
J Clin Oncol; 1997 Feb; 15(2):712-22. PubMed ID: 9053497
[TBL] [Abstract][Full Text] [Related]
11. [Is there a place for surgical management in stage IIIA N2 non-small cell lung cancer?].
Pagès PB; Pforr A; Delpy JP; Abou Hanna H; Bernard A
Rev Mal Respir; 2015 May; 32(5):485-92. PubMed ID: 25498767
[TBL] [Abstract][Full Text] [Related]
12. Surgery as a Component of Multimodality Care for Known Stage IIIA-N2 Non-small Cell Lung Cancer.
Bograd AJ; Vallières E
Semin Respir Crit Care Med; 2020 Jun; 41(3):346-353. PubMed ID: 32450588
[TBL] [Abstract][Full Text] [Related]
13. Induction Chemoradiotherapy (50 Gy), Followed by Resection, for Stage IIIA-N2 Non-Small Cell Lung Cancer.
Tanaka F; Yokomise H; Soejima T; Uramoto H; Yamanaka T; Nakagawa K; Yamamoto N; Nishimura Y; Niwa H; Okada M; Nakagawa T; Yamashita M
Ann Thorac Surg; 2018 Oct; 106(4):1018-1024. PubMed ID: 29890150
[TBL] [Abstract][Full Text] [Related]
14. Role of surgery in N2 NSCLC: pros.
Shien K; Toyooka S
Jpn J Clin Oncol; 2016 Dec; 46(12):1168-1173. PubMed ID: 27655902
[TBL] [Abstract][Full Text] [Related]
15. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805.
Albain KS; Rusch VW; Crowley JJ; Rice TW; Turrisi AT; Weick JK; Lonchyna VA; Presant CA; McKenna RJ; Gandara DR
J Clin Oncol; 1995 Aug; 13(8):1880-92. PubMed ID: 7636530
[TBL] [Abstract][Full Text] [Related]
16. Advances in the use of surgery and multimodality treatment for N2 non-small cell lung cancer.
Van Schil PE; Yogeswaran K; Hendriks JM; Lauwers P; Faivre-Finn C
Expert Rev Anticancer Ther; 2017 Jun; 17(6):555-561. PubMed ID: 28403675
[TBL] [Abstract][Full Text] [Related]
17. The Optimal Treatment for Stage IIIA-N2 Non-Small Cell Lung Cancer: A Network Meta-Analysis.
Zhao Y; Wang W; Liang H; Yang CJ; D'Amico T; Ng CSH; Liu CC; Petersen RH; Rocco G; Brunelli A; Liu J; He J; Huang W; Liang W; He J;
Ann Thorac Surg; 2019 Jun; 107(6):1866-1875. PubMed ID: 30557543
[TBL] [Abstract][Full Text] [Related]
18. A preoperative alternating chemotherapy and radiotherapy program for patients with stage IIIA (N2) non-small cell lung cancer.
Takamori S; Rikimaru T; Hayashi A; Tayama K; Mitsuoka M; Fujimoto K; Horiuchi M; Hayabuchi N; Oizumi K; Shirouzu K
Lung Cancer; 2000 Jul; 29(1):49-56. PubMed ID: 10880847
[TBL] [Abstract][Full Text] [Related]
19. Is trimodality approach better then bimodality in stage IIIA, N2 positive non-small cell lung cancer?
Park BB; Park JO; Kim H; Ahn YC; Choi YS; Kim K; Kim J; Shim YM; Ahn JS; Park K
Lung Cancer; 2006 Sep; 53(3):323-30. PubMed ID: 16844258
[TBL] [Abstract][Full Text] [Related]
20. [Management of resectable non-small cell lung cancer. Guidelines of clinical practice made by the European Lung Cancer Working Party].
European Lung Cancer Working Party
Rev Med Brux; 2006; 27(1):29-38. PubMed ID: 16608009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
